Alamar Biosciences Inc (ALMR): Next-Year EPS Estimate 30.37%
As of 2026-11-12, Alamar Biosciences Inc (ALMR) has a next-year EPS growth estimate of 30.37%. Featured in 2 EPS revision reports, most recently on 2026-10-23.
On 2026-11-04, analyst consensus for ALMR's next-year EPS growth shifted from 49.13% to 30.37% — a negative change of 18.76 percentage points. The revised estimate has been sustained across 8 subsequent trading sessions. Current-year growth is projected at -467.62%.
What's Driving This
No EPS estimate upgrade is evident in the provided data; instead, on 2026-11-04 analysts lowered ALMR’s next-year EPS growth estimate from 49.13% to 30.37%. No recent headlines were available to identify a catalyst such as an earnings beat, contract win,
Generated 2026-11-12 from news as of 2026-11-12
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Devices
- EPS growth next year
- 30.37%
- EPS growth this year
- -467.62%
- EPS next quarter (est)
- -$0.26
- Last price
- $31.76
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 30.37% | -467.62% | -$0.26 | $31.76 |
| 2026-11-11 | 30.37% | -467.62% | -$0.26 | $31.61 |
| 2026-11-10 | 30.37% | -467.62% | -$0.26 | $31.50 |
| 2026-11-09 | 30.37% | -467.62% | -$0.26 | $31.84 |
| 2026-11-07 | 30.37% | -467.62% | -$0.26 | $28.05 |
| 2026-11-06 | 30.37% | -467.62% | -$0.26 | $28.05 |
| 2026-11-05 | 30.37% | -467.62% | -$0.26 | $26.91 |
| 2026-11-04 | 30.37% | -467.62% | -$0.26 | $27.39 |
| 2026-11-03 | 49.13% | -455.49% | N/A | $30.22 |
| 2026-11-02 | 49.13% | -455.49% | -$0.20 | $28.94 |
| 2026-10-31 | 49.13% | -455.49% | -$0.20 | $30.60 |
| 2026-10-30 | 49.13% | -455.49% | -$0.20 | $30.60 |
| 2026-10-29 | 49.13% | -455.49% | -$0.20 | $34.04 |
| 2026-10-28 | 49.13% | -455.49% | -$0.20 | $34.30 |
| 2026-10-27 | 49.13% | -455.49% | -$0.20 | $31.93 |
| 2026-10-26 | 49.13% | -455.49% | -$0.20 | $30.39 |
| 2026-10-23 | 49.13% | -455.49% | -$0.20 | $30.69 |
| 2026-10-22 | 49.13% | -455.49% | -$0.20 | $29.72 |
| 2026-10-21 | 49.13% | -455.49% | -$0.20 | $31.45 |
| 2026-10-20 | 49.13% | -455.49% | -$0.20 | $28.16 |
| 2026-10-19 | 49.13% | -455.49% | -$0.20 | $26.30 |
| 2026-10-16 | 49.13% | -455.49% | -$0.20 | $25.28 |
| 2026-10-15 | 49.13% | -455.49% | -$0.20 | $27.42 |
| 2026-10-14 | 49.13% | -455.49% | -$0.20 | $25.37 |
| 2026-10-13 | 45.32% | -480.00% | -$0.21 | $23.52 |
| 2026-10-12 | 45.32% | -480.00% | -$0.21 | $24.24 |
| 2026-10-11 | 45.32% | -480.00% | -$0.21 | $25.27 |
| 2026-10-10 | 45.32% | -480.00% | -$0.21 | $25.27 |
| 2026-10-09 | 45.32% | -480.00% | -$0.21 | $25.27 |
| 2026-10-08 | 45.32% | -480.00% | -$0.21 | $25.91 |
Reports Featuring ALMR
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is Alamar Biosciences Inc's next-year EPS growth estimate?▾
As of 2026-11-12, Alamar Biosciences Inc (ALMR) has a next-year EPS growth estimate of 30.37%, based on analyst consensus.
When was the latest EPS estimate revision for ALMR?▾
The most recent revision occurred on 2026-11-04, when analysts adjusted the next-year EPS growth estimate from 49.13% to 30.37%.
What sector and industry does Alamar Biosciences Inc belong to?▾
Alamar Biosciences Inc operates in the Healthcare sector, specifically the Medical Devices industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. ALMR appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Alamar Biosciences Inc (ALMR) appears here because it was detected by our daily top-EPS-revision-performer screen.